Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

The research team at the Shenzhen Institutes of Advanced Technology of the Chinese Academy of Sciences confirmed the ...

A new study has identified the protein hnRNP A1 as a key player in the production and maintenance of myelin, the fatty sheath ...

Monument Therapeutics, a precision-neuroscience company focused on the development of innovative treatments for serious central nervous system disorders (CNS), today announced two key leadership ...

April is Parkinson’s Awareness Month and, according to the Parkinson's Foundation, nearly 90,000 people in the US are ...